Drugmaker Amgen last week extended its existing 340B contract pharmacy restrictions to federal grantees.
Amgen Extends Contract Pharmacy Restrictions to Grantees, Receives Early Pushback
Views
Biopharmaceutical manufacturer Amgen recently expanded its conditions on 340B pricing at contract pharmacies to include grantees. The Thousand Oaks, California-based [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.